SGHT SEC Filing News — Sight Sciences, Inc.

Latest SEC filings for Sight Sciences, Inc. (SGHT) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-05.

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure…
Sector: Healthcare Industry: Medical Devices Market Cap: $455.0M
20
Total Filings
0
Bullish Classifications
5
Bearish Classifications
6
Insider Transactions
0
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for SGHT currently lean bearish. Of the 20 filing records displayed, 5 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
SGHT Filing Activity Snapshot 2026-08-11 — 2026-10-05
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$395.9K
HAYDEN JEREMY B. · 2026-08-14
48,000 shares · Form 144
Form 144 Notices
14
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 6 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 6 filings in this group are Form 4s for Sight Sciences, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 6 insider filings shown, the breakdown is 5 open-market sale and 1 compensation award. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×1
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Open-market sale Insider Selling 2026-10-05

SGHT insider Taylor Brenton (EVP, Operations & R&D) sold 2,988 shares (~$26.5K)

Taylor Brenton, listed as EVP, Operations & R&D at Sight Sciences, Inc., reported an open-market sale of 2,988 SGHT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,988 $8.85 $26.5K
Filing: Form 4 (Insider Transaction) Insider: Taylor Brenton (EVP, Operations & R&D) Shares: 2,988 Est. Value: $26.5K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-05

SGHT insider Bauerlein Alison (Chief Operating Officer) sold 25,260 shares (~$223.6K)

Bauerlein Alison, listed as Chief Operating Officer at Sight Sciences, Inc., reported an open-market sale of 25,260 SGHT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 25,260 $8.85 $223.6K
Filing: Form 4 (Insider Transaction) Insider: Bauerlein Alison (Chief Operating Officer) Shares: 25,260 Est. Value: $223.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-05

SGHT insider Rodberg James (Chief Financial Officer) sold 7,208 shares (~$63.8K)

Rodberg James, listed as Chief Financial Officer at Sight Sciences, Inc., reported an open-market sale of 7,208 SGHT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 7,208 $8.85 $63.8K
Filing: Form 4 (Insider Transaction) Insider: Rodberg James (Chief Financial Officer) Shares: 7,208 Est. Value: $63.8K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-05

SGHT insider Badawi David (Director, Chief Technology Officer) sold 7,797 shares (~$70.6K)

Badawi David, listed as Director, Chief Technology Officer at Sight Sciences, Inc., reported an open-market sale of 7,797 SGHT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 7,797 $9.05 $70.6K
Filing: Form 4 (Insider Transaction) Insider: Badawi David (Director, Chief Technology Officer) Shares: 7,797 Est. Value: $70.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-05

SGHT insider Badawi Paul (Director, President and CEO, 10% Owner) sold 29,653 shares (~$268.3K)

Badawi Paul, listed as Director, President and CEO, 10% Owner at Sight Sciences, Inc., reported an open-market sale of 29,653 SGHT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 29,653 $9.05 $268.3K
Filing: Form 4 (Insider Transaction) Insider: Badawi Paul (Director, President and CEO, 10% Owner) Shares: 29,653 Est. Value: $268.3K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

SGHT insider Form 4 filed for equity award, exercise, or tax withholding

Rashid Kashif (Chief Legal Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 181,818 — —
Filing: Form 4 (Insider Transaction) Insider: Rashid Kashif (Chief Legal Officer) Shares: 181,818
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 14 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Sight Sciences, Inc. has 14 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-02

SGHT Form 144 filed for proposed insider sale by Bauerlein Alison (25,260 shares) ~$223.6K

Bauerlein Alison filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Bauerlein Alison Shares: 25,260 Est. Value: $223.6K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-02

SGHT Form 144 filed for proposed insider sale by Taylor Brenton (2,988 shares) ~$26.5K

Taylor Brenton filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Taylor Brenton Shares: 2,988 Est. Value: $26.5K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-02

SGHT Form 144 filed for proposed insider sale by Rodberg James (7,208 shares) ~$63.8K

Rodberg James filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Rodberg James Shares: 7,208 Est. Value: $63.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-01

SGHT Form 144 filed for proposed insider sale by Badawi Paul (29,653 shares) ~$268.3K

Badawi Paul filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Badawi Paul Shares: 29,653 Est. Value: $268.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-01

SGHT Form 144 filed for proposed insider sale by Badawi David (7,797 shares) ~$70.6K

Badawi David filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Badawi David Shares: 7,797 Est. Value: $70.6K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-01

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (2,746 shares) ~$24.8K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 2,746 Est. Value: $24.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-30

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (22,254 shares) ~$208.1K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 22,254 Est. Value: $208.1K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-04

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (12,219 shares) ~$101.3K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 12,219 Est. Value: $101.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-01

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (13,253 shares) ~$110.0K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 13,253 Est. Value: $110.0K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-17

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (12,014 shares) ~$97.8K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 12,014 Est. Value: $97.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-14

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (48,000 shares) ~$395.9K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 48,000 Est. Value: $395.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-13

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (2,500 shares) ~$20.8K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 2,500 Est. Value: $20.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-12

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (16,302 shares) ~$133.3K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 16,302 Est. Value: $133.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-11

SGHT Form 144 filed for proposed insider sale by HAYDEN JEREMY B. (20,918 shares) ~$165.9K

HAYDEN JEREMY B. filed a Form 144 with the SEC indicating intent to sell SGHT (Sight Sciences, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HAYDEN JEREMY B. Shares: 20,918 Est. Value: $165.9K
View on SEC EDGAR → Open Filing Document →

How we classify Sight Sciences, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on SGHT. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — SGHT SEC Filings

More Tools for SGHT

SGHT Full Stock Analysis SGHT Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper SGHT analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the SGHT stock analysis page.

SGHT Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer